2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole-D4; 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-4,5,6,7-d4; (±)-Rabeprazole-d4; 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-d4; 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole-d4; 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfinyl]benzimidazole-d4; 2-[[[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methyl]sulfinyl]-1H-benzimidazole;-d4 Habeprazole-d4; LY 307640-d4; Newprazole-d4; Pariets-d4; Rabeloc-d4; Rabemax-d4; Rabiral-d4
Rabeprazole-d4 is a fully characterized chemical compound used as a reference standard of API Rabeprazole. The standard offered is compliant with regulatory guidelines. Rabeprazole-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 934295-48-4
Related products
Rabeprazole EP Impurity A-d3 (Rabeprazole Sulfone-d3)
M.F.
M.W. 378.46
CAT# AR-R01033
CAS# 1330261-33-0
